Expression of renal 11β-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function

被引:40
|
作者
Quinkler, M
Zehnder, D
Lepenies, J
Petrelli, MD
Moore, JS
Hughes, SV
Cockwell, P
Hewison, M
Stewart, PM [1 ]
机构
[1] Univ Birmingham, Sch Med, Div Med Sci, Queen Elizabeth Hosp, Birmingham B15 2TT, W Midlands, England
[2] Univ Birmingham, Sch Med, Dept Nephrol, Queen Elizabeth Hosp, Birmingham B15 2TT, W Midlands, England
[3] Charite Univ Med Belin, Div Clin Endocrinol, Berlin, Germany
关键词
D O I
10.1530/eje.1.01954
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Renal 11 beta-hydroxysteroid dehydrogenase type 2 (11 beta-HSD2) enables selective access of aldosterone to the mineralocorticoid receptor (MR). Impaired 11 beta-HSD2 activity has been suggested in patients with hypertension as well as in patients with renal disease, where it may contribute to sodium retention, oedema and hypertension. To date, these studies have relied upon urinary cortisol (F) metabolite levels as surrogate markers of renal 11 beta-HSU2 activity. Methods: We have directly analysed renal 11 beta-HSD2 mRNA expression in 95 patients undergoing kidney biopsy using TaqMan real-time PCR. Serum and 24-h urine samples were used to document underlying renal function and endocrine parameters. Urinary F and cortisone (E) metabolites were analysed using gas chromatography/mass spectrometry. Results: Expression of 11 beta-HSD2 did not correlate with blood pressure or urinary Na/K ratio, but a significant positive correlation with creatinine clearance was observed (r = 0.284; P < 0.01). Immunofluorescence and confocal laser microscopy confirmed decreased 11 beta-HSD2 expression in patients with impaired renal function. For the first time, we showed that 11 beta-HSD2 mRNA expression correlated negatively with the urinary free (UF) F/E (UFF/UFE) ratio (r = 0.276; P < 0.05) as well as with the urinary tetrahydrocortisol + 5 alpha-tetrahydrocortisol/tetrahydrocortisone ((THF + alpha THF)/THE) ratio (r = 0.256; P < 0.05). No difference in 11 beta-HSD2 mRNA expression or in the UFF/UFE ratio was found between groups with no proteinuria, microalbummuria, moderate or severe proteinuria. In contrast, the urinary (THF + alpha THF)/THE ratio increased significantly (P < 0.05) in patients with severe albuminuria, suggesting increased hepatic 11 beta-HSD1 in those patients. Conclusions: These data suggest that renal 11 beta-HSD2 expression may be represented only marginally better, if at all, by the UFF/UFE than by the (THF + alpha THF)/THE ratio. Reduced renal 11 beta-HSD2 expression may lead to occupancy of the MR by glucocorticoids such as cortisol and may contribute to the increased sodium retention seen in patients with impaired renal function.
引用
收藏
页码:291 / 299
页数:9
相关论文
共 50 条
  • [41] ALTERATION OF PLACENTAL TYPE 2 11β-HYDROXYSTEROID DEHYDROGENASE EXPRESSION AND ACTIVITY BY LEAD
    St-Pierre, Joey
    Fraser, Marc
    Vaillancourt, Cathy
    PLACENTA, 2014, 35 (09) : A111 - A111
  • [42] Expression of 11beta-hydroxysteroid-dehydrogenase type 2 in human thymus
    Almanzar, Giovanni
    Mayerl, Christina
    Seitz, Jan-Christoph
    Hoefner, Kerstin
    Brunner, Andrea
    Wild, Vanessa
    Jahn, Daniel
    Geier, Andreas
    Fassnacht, Martin
    Prelog, Martina
    STEROIDS, 2016, 110 : 35 - 40
  • [43] Decreased activity of 11β-hydroxysteroid dehydrogenase in patients with Cushing's syndrome
    Stiefel, P
    Jiménez, L
    García-Morillo, JS
    Leal, A
    Villar, J
    Carneado, J
    MEDICINA CLINICA, 2000, 115 (03): : 90 - 92
  • [44] Effect of angiotensin II on rat renal cortical 11β-hydroxysteroid dehydrogenase
    Hermans, JJR
    Fischer, MAJ
    Schiffers, PM
    Struijker-Boudier, HAJ
    ENDOCRINE, 2000, 13 (03) : 393 - 399
  • [45] Effect of angiotensin II on rat renal cortical 11β-hydroxysteroid dehydrogenase
    J. J. Rob Hermans
    Marc A. J. Fischer
    Paul M. Schiffers
    Harry A. J. Struijker-Boudier
    Endocrine, 2000, 13 : 393 - 399
  • [46] 11-BETA-HYDROXYSTEROID DEHYDROGENASE IN RENAL COLLECTING DUCT CELLS
    NARAYFEJESTOTH, A
    FEJESTOTH, G
    STEROIDS, 1994, 59 (02) : 105 - 110
  • [47] Increased expression of 11β-hydroxysteroid dehydrogenase type 2 in the lungs of patients with acute respiratory distress syndrome
    Suzuki, S
    Tsubochi, H
    Ishibashi, H
    Suzuki, T
    Kondo, T
    Sasano, H
    PATHOLOGY INTERNATIONAL, 2003, 53 (11) : 751 - 756
  • [48] Cortisol and 11 beta-hydroxysteroid dehydrogenase type 2 as potential determinants of renal citrate excretion in healthy children
    Yifan Hua
    Jonas Esche
    Michaela F. Hartmann
    Christiane Maser-Gluth
    Stefan A. Wudy
    Thomas Remer
    Endocrine, 2020, 67 : 442 - 448
  • [49] Cortisol and 11 beta-hydroxysteroid dehydrogenase type 2 as potential determinants of renal citrate excretion in healthy children
    Hua, Yifan
    Esche, Jonas
    Hartmann, Michaela F.
    Maser-Gluth, Christiane
    Wudy, Stefan A.
    Remer, Thomas
    ENDOCRINE, 2020, 67 (02) : 442 - 448
  • [50] 11 Beta-Hydroxysteroid Dehydrogenase Type2 Promoter Polymorphisms Determines a Decreased HSD11B2 Expression in Vivo
    Carvajal, Cristian A.
    Tapia-Castillo, Alejandra
    Vidal, Araceli
    Valdivia, Carolina
    Campino, Carmen
    Lagos, Carlos F.
    Vecchiola, Andrea
    Fuentes, Cristobal A.
    Martinez-Aguayo, Alejandro
    Aglony, Marlene
    Garcia, Hernan
    Friso, Simonetta
    Olivieri, Oliviero
    Fardella, Carlos E.
    ENDOCRINE REVIEWS, 2014, 35 (03)